Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

TSXV:KNE - Post Discussion

Kane Biotech Inc > Apart from traveling
View:
Post by RoyMax123 on Jun 13, 2024 10:04am

Apart from traveling

it seems that nothing happen, still no production, no acne trial etc... I won't be surprise if they run out of cash before anything serious happen.
Comment by francoisl13 on Jun 13, 2024 10:12am
The next big news will be the start of the 'Revyve' commercial production (before end of June, per KNE) and product shipment to Progenacare. This should prevent them to run out of cash for a little while... It was said that the ACNE trial and the Dispersin B phase 1 study could start a little later than what was expected but, things are moving forward, just at a slower pace. The above is ...more  
Comment by RoyMax123 on Jun 13, 2024 12:43pm
Hopefully that "before end of June" deadline will be more accurate than all others deadline they gave in the past.
Comment by francoisl13 on Jun 13, 2024 12:56pm
100% agree with your comment about KNE typically not meeting deadlines...deadlines that they are setting themself...I think that they should be using a more conservative approach when mentioning deadlines, that way they will not disappoint the investment community and, their own shareholders.
Kane Biotech Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities